Berman Capital Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $47K | Buy |
147
+89
| +153% | +$28.5K | 0.01% | 709 |
|
2021
Q2 | $18K | Buy |
58
+7
| +14% | +$2.17K | ﹤0.01% | 959 |
|
2021
Q1 | $16K | Buy |
51
+14
| +38% | +$4.39K | ﹤0.01% | 880 |
|
2020
Q4 | $11K | Buy |
37
+21
| +131% | +$6.24K | ﹤0.01% | 910 |
|
2020
Q3 | $4K | Hold |
16
| – | – | ﹤0.01% | 1151 |
|
2020
Q2 | $3K | Buy |
16
+4
| +33% | +$750 | ﹤0.01% | 1201 |
|
2020
Q1 | $1K | Buy |
12
+4
| +50% | +$333 | ﹤0.01% | 1415 |
|
2019
Q4 | $1K | Sell |
8
-27
| -77% | -$3.38K | ﹤0.01% | 1422 |
|
2019
Q3 | $6K | Sell |
35
-14
| -29% | -$2.4K | ﹤0.01% | 918 |
|
2019
Q2 | $12K | Buy |
49
+23
| +88% | +$5.63K | ﹤0.01% | 676 |
|
2019
Q1 | $7K | Buy |
26
+5
| +24% | +$1.35K | ﹤0.01% | 795 |
|
2018
Q4 | $6K | Buy |
+21
| New | +$6K | ﹤0.01% | 656 |
|